Navigation Links
Georgia Health Sciences University Clinical Study Shows RyMed InVision-Plus® IV Connector Significantly Decreased Central Venous Catheter Occlusions in Oncology Patients
Date:2/16/2011

FRANKLIN, Tenn., Feb. 16, 2011 /PRNewswire/ -- Georgia Health Sciences University presented a poster at the recent 11th National Conference on Cancer Nursing Research in Los Angeles, in which their clinical study showed that RyMed Technologies' InVision-Plus® IV Connector significantly decreased venous catheter occlusions in patients from both outpatient and inpatient cancer clinical settings. The study compared one simple split septum negative displacement IV connector (Becton-Dickinson Q-Syte®) against a zero fluid displacement connector (RyMed's InVision-Plus® IV Connector).

Venous access catheters and needleless IV connectors are a necessary part of cancer patient treatment. Thrombotic occlusions, which are blood clots within the catheter lumen, are a significant complication of vascular access catheters and IV connectors that can lead in some instances to a partial or totally occluded catheter and potentially lead to biofilm development and deadly bloodstream infections.

Dr. Cynthia C. Chernecky PhD, RN, AOCN, FAAN at Georgia Health Sciences University was the lead presenter of the clinical poster. The overall reductions in occlusion rates were significant with the InVision-Plus® IV Connector. The pediatric outpatient population saw a 93% reduction in occlusions. This is particularly significant since the primary care for this group of patients is the parent or the clinical personnel where the patient lives. The zero fluid displacement connector averaged a 73% reduction in occlusion rates versus the split septum negative displacement IV connector in the three departments evaluated; ICU, inpatient and outpatient populations.

Dr. Chernecky stated, "The prevention of occlusions is paramount in the oncology patient as potential loss of venous access and resulting delays of treatment can be harmful and lead to unnecessary pain. Use of best technology is what each patient deserves."

The Chernecky clinical data is an addition to the growing body of evidence associating various negative and positive displacement split-septum and mechanical valves with increased rates of complications, whether catheter-related bloodstream infections or intraluminal thrombotic occlusions.

"Evidence-based occlusion studies are rare, especially in outpatient pediatric oncology populations. Reducing and/or eliminating occlusions will negate treatment delays, add time to nursing and physician care, decrease cost, decrease mortalities and increase the quality of life for patients and their family. This is a clear evaluation and indication by the numbers that the InVision-Plus® is the best needleless IV connector for patients," said Dana Wm. Ryan, President and CEO, RyMed Technologies.

About RyMed Technologies, Inc.

Founded in 1994, RyMed Technologies specializes in the development and marketing of innovative safety products in the field of intravenous catheter care management. The company's products are designed to help reduce catheter-related bloodstream infections (CR-BSIs) and intraluminal thrombotic catheter occlusions associated with needleless IV connectors. More than 10 years of research and development have gone into InVision-Plus® IV Connector. In January, 2011 the Company introduced the first chlorhexidine/silver ion technology with the new InVision-Plus® CS™. For more information, call (615) 790-8093 or access www.rymedtech.com.

Media Contact:

Glen Calder

561-750-9800 x216

gcalder@transmediagroup.com


'/>"/>
SOURCE RyMed Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Ceres Trials Energy Crops at Georgia Biofuel Facility
2. Update: Georgia and North Carolina Teens Honored for Research in Biochemistry and Genetics in Nations Premier High School Science Competition
3. Researchers at the University of Georgia Discover Protein is Crucial to Reproduction of Parasites Involved in Disease
4. The Biotechnology Industry Organization Honors Georgia Governor Sonny Perdue as Governor of the Year
5. Natural Fuels Industries Eyes Biomass Rich Georgia for Production Facility
6. Vega Picks Tennessee Firm to Assist with Construction of Biomass Plant in Georgia
7. Big Win for Huge Coral Reefs off NC, SC, Georgia, Florida
8. GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia
9. Arts Way Manufacturing Announces Contract for Modular Swine Facility for the University of Georgia
10. Georgia Power to Delay Plant Mitchell Conversion to Biomass
11. Georgia Techs Walt de Heer awarded Materials Research Society Medal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... September 21, 2017 , ... When a downtown ... response was swift and efficient thanks to the continuing efforts of members of ... of more than 50 stakeholders, including officials from area counties and cities, Renewable ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... that it has appointed Vishwas Paralkar to the role of chief scientific officer. ... technology. He will report to Cybrexa’s president and CEO, Per Hellsund. , “I ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... examining the effects of exoskeleton-assisted walking on gait parameters and neuromuscular activity ... "Neuromechanical adaptations during a robotic powered exoskeleton assisted walking session" (doi:10.1080.10790268.2017.1314900) was ...
(Date:9/19/2017)... ... September 19, 2017 , ... The latest ... dangerous step of sample prep for metals digestion—the addition of acids and reagents. ... affordable price. The system is ideal for any laboratory performing their own unique ...
Breaking Biology Technology:
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
Breaking Biology News(10 mins):